Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gennaro Prisco
Observed names:
G Prisco,
G. Prisco
Institution:
European Institute of Oncology
Observed institutions:
University of Milan,
European Institute of Oncology
OpenAlex ID:
A5052020344
Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.
1998
·
C De Cicco
, M Cremonesi
, et al.
·
PubMed
·
200
Pre-Targeted Locoregional Radioimmunotherapy with 90 Y-biotin in Glioma Patients: Phase I Study and Preliminary Therapeutic Results
2001
·
G. Paganelli
, M. Bartolomei
, et al.
·
Cancer Biotherapy and Radiopharmaceuticals
·
136
Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspects.
2002
·
C De Cicco
, M Pizzamiglio
, et al.
·
PubMed
·
107
Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients
1999
·
Marta Cremonesi
, Mahila Ferrari
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
96
Optimised nuclear medicine method for tumour marking and sentinel node detection in occult primary breast lesions
2003
·
C. De Cicco
, G. Trifirò
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
94
Internal mammary node lymphoscintigraphy and biopsy in breast cancer.
2002
·
G Paganelli
, V Galimberti
, et al.
·
PubMed
·
93
Optimized sentinel node scintigraphy in breast cancer.
1998
·
G Paganelli
, C De Cicco
, et al.
·
PubMed
·
86
Radiation protection in radionuclide therapies with 90Y-conjugates: risks and safety
2006
·
Marta Cremonesi
, Mahila Ferrari
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
60
High-Dose Radioimmunotherapy with 90Y-Ibritumomab Tiuxetan: Comparative Dosimetric Study for Tailored Treatment
2007
·
M. Cremonesi
, M. Ferrari
, et al.
·
Journal of Nuclear Medicine
·
55
PDF
Is [18F] fluorodeoxyglucose uptake by the primary tumor a prognostic factor in breast cancer?
2012
·
Concetta De Cicco
, Laura Gilardi
, et al.
·
The Breast
·
30
PDF
Neoadjuvant therapy in locally advanced breast cancer: 99mTc-MIBI mammoscintigraphy is not a reliable technique to predict therapy response
2007
·
Laura Lavinia Travaini
, Silvia Melania Baio
, et al.
·
The Breast
·
13
Clinical Utility of 99m Tc-Sestamibi Scintimammography in the Management of Equivocal Breast Lesions
2004
·
Concetta De Cicco
, Giuseppe Trifirò
, et al.
·
Cancer Biotherapy and Radiopharmaceuticals
·
5
Acquisition protocol for breast cancer imaging with technetium-99m-labeled synthetic peptide and technetium-99m-MDP.
1997
·
M Fiorenza
, G Prisco
, et al.
·
PubMed
·
1
177Lu-DOTATATE receptor radionuclide therapy: Internal dosimetry estimates and considerations for practical protocols
2011
·
Marta Cremonesi
, Giuseppina Amalia Di Dia
, et al.
·
Journal of Nuclear Medicine
31 P - Immunolymphoscintigraphy and sentinel node biopsy in melanoma
1996
·
A. Testori
, C. Grana
, et al.
·
European Journal of Cancer
Show more works
View as search
Works count:
15
Citation count:
976
H-index:
11
I10-index:
11
Year
Topic
Type
